HY-021068

N/A

Report date: 2024/12/17 20:00:06
NME

Base Information

Drug NameHY-021068
Drug Alias NameHY-021068
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsScleroderma, SystemicThromboembolismStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHefei Industrial Pharmaceutical Co LtdGuangzhou Bo Teng Biomedical Technology Co LtdNanjing Medical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHefei Amvite Pharmaceuticals Co LtdGuangzhou Bo Teng Biomedical Technology Co LtdHefei Industrial Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicThromboembolismStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A